DUSA Pharmaceuticals, Inc.

Quick facts

Phase 2 pipeline

• Broad Area ALA 1-hour incubation · Dermatology
  ALA (5-aminolevulinic acid) is a precursor to porphyrins, which accumulate in abnormal cells and become fluorescent under blue light, allowing for photodynamic therapy.
• Broad Area ALA 2 hour incubation · Dermatology
  ALA (5-aminolevulinic acid) is a precursor to porphyrins, which accumulate in abnormal cells and become fluorescent under blue light, allowing for photodynamic therapy.
• broad area ALA 3-hour incubation
• Spot ALA 2 hour incubation

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• DUSA Pharmaceuticals, Inc. portfolio CI brief
• DUSA Pharmaceuticals, Inc. pipeline updates RSS